Oral treatment for COVID-19 (IMAGE) University of Texas at Austin Caption Drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures, according to new study. Credit Illustration credit: Jenna Luecke/University of Texas at Austin. Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.